Papers authored by Thivat E

Collect these papers and discover other ones on Labmeeting. Learn more.
Loss of Bcl-2 expression in colon cancer: a prognostic factor for recurrence in stage II colon cancer.
+ cite this
+ View Abstract
Poincloux L, Durando X, Seitz JF, Thivat E, Bardou VJ, Giovannini MH, Parriaux D, Barriere N, Giovannini M, Delpero JR, and Monges G
Surgical oncology 18(4):357-65, 2009 Dec - Who cited this? | PubMed ID: 19027288 | Fulltext
Recommend
Metastatic breast cancer: overall survival related to successive chemotherapies. What do we gain after the third line?.
+ cite this
+ View Abstract
Tacca O, Leheurteur M, Durando X, Mouret-Reynier MA, Abrial C, Thivat E, Bayet-Robert M, Penault-Llorca F, and Chollet P
Cancer investigation 27(1):81-5, 2009 Jan - Who cited this? | PubMed ID: 19191099 | Fulltext
Recommend
Combined methionine deprivation and chloroethylnitrosourea have time-dependent therapeutic synergy on melanoma tumors that NMR spectroscopy-based metabolomics explains by methionine and phospholipid metabolism reprogramming.
+ cite this
+ View Abstract
Guenin S, Morvan D, Thivat E, Stepien G, and Demidem A
Nutrition and cancer 61(4):518-29, 2009 - Who cited this? | PubMed ID: 19838924 | Fulltext
Recommend
Changes and Predictive and Prognostic Value of the Mitotic Index, Ki-67, Cyclin D1, and Cyclo-oxygenase-2 in 710 Operable Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
+ cite this
+ View Abstract
Penault-Llorca F, Abrial C, Raoelfils I, Chollet P, Cayre A, Mouret-Reynier MA, Thivat E, Mishellany F, Gimbergues P, and Durando X
The oncologist 13(12):1235-45, 2008 Dec - Who cited this? | PubMed ID: 19091781 | Fulltext
Recommend
Measurement of residual disease after neoadjuvant chemotherapy.
+ cite this
Abrial C, Thivat E, Tacca O, Durando X, Mouret-Reynier MA, Gimbergues P, Penault-Llorca F, and Chollet P
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 26(18):3094; author reply 3095, 2008 Jun 20 - Who cited this? | PubMed ID: 18565900 | Fulltext
Recommend
A new prognostic classification after primary chemotherapy for breast cancer: residual disease in breast and nodes (RDBN).
+ cite this
+ View Abstract
Chollet P, Abrial C, Durando X, Thivat E, Tacca O, Mouret-Reynier MA, Leheurteur M, Kwiatkowski F, Dauplat J, and Penault-Llorc F
Cancer journal (Sudbury, Mass.) 14(2):128 - Who cited this? | PubMed ID: 18391619 | Fulltext
Recommend
[Methionine dependency of cancer cells: a new therapeutic approach?].
+ cite this
+ View Abstract
Durando X, Thivat E, Gimbergues P, Cellarier E, Abrial C, Dib M, Tacca O, and Chollet P
Bulletin du cancer 95(1):69-76, 2008 Jan 1 - Who cited this? | PubMed ID: 18230572 | Fulltext
Recommend
Optimal methionine-free diet duration for nitrourea treatment: a phase I clinical trial.
+ cite this
+ View Abstract
Durando X, Thivat E, Farges MC, Cellarier E, D'Incan M, Demidem A, Vasson MP, Barthomeuf C, and Chollet P
Nutrition and cancer 60(1):23-30, 2008 - Who cited this? | PubMed ID: 18444132 | Fulltext
Recommend
Temozolomide treatment of an adult with a relapsing medulloblastoma.
+ cite this
+ View Abstract
Durando X, Thivat E, Gilliot O, Irthum B, Verrelle P, Vincent C, and Bay JO
Cancer investigation 25(6):470-5, 2007 Sep - Who cited this? | PubMed ID: 17882660 | Fulltext
Recommend
A methionine-free diet associated with nitrosourea treatment down-regulates methylguanine-DNA methyl transferase activity in patients with metastatic cancer.
+ cite this
+ View Abstract
Thivat E, Durando X, Demidem A, Farges MC, Rapp M, Cellarier E, Guenin S, D'Incan M, Vasson MP, and Chollet P
Anticancer research 27(4C):2779-83, 2007 - Who cited this? | PubMed ID: 17695447 | Fulltext
Recommend
Cystemustine in recurrent high grade glioma.
+ cite this
+ View Abstract
Durando X, Thivat E, Roché H, Bay JO, Lemaire JJ, Verrelle P, Chazal J, Curé H, and Chollet P
Journal of neuro-oncology 79(1):33-7, 2006 Aug - Who cited this? | PubMed ID: 16575534 | Fulltext
Recommend
Second-line chemotherapy of disseminated malignant melanoma with cystemustine at 60 mg/m2: a phase II trial.
+ cite this
+ View Abstract
Thivat E, Durando X, D'Incan M, Cure H, Mouret-Reynier MA, Madelmont JC, Souteyrand P, and Chollet P
Anti-cancer drugs 16(9):1003-7, 2005 Oct - Who cited this? | PubMed ID: 16162977 | Fulltext
Recommend
Long-term disease-free survival in advanced melanomas treated with nitrosoureas: mechanisms and new perspectives.
+ cite this
+ View Abstract
Durando X, Thivat E, D'Incan M, Sinsard A, Madelmont JC, and Chollet P
BMC cancer 5:147, 2005 - Who cited this? | PubMed ID: 16287507 | Fulltext
Recommend



Search Google Scholar for Thivat E

Join Labmeeting

  • Organize and search your PDF collection
  • Collect papers
  • Search millions of papers
  • Keep up to date with paper alerts
  • Read your papers from anywhere
  • Recommend papers to colleagues
  • Manage your lab
Sign Up

Join Labmeeting

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.


Sponsored Product



Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!